<?xml version="1.0" encoding="UTF-8"?>
<EmailTemplate xmlns="http://soap.sforce.com/2006/04/metadata">
    <available>true</available>
    <description>For trial matches within GAP</description>
    <encodingKey>ISO-8859-1</encodingKey>
    <name>GAP Initial Outreach Email</name>
    <style>none</style>
    <subject>Your patient {!Match_Record__c.Patient_Last__Name__c}’s genomic alteration indicates potential clinical trial match</subject>
    <textOnly>Dear Dr. {!Match_Record__c.MD_Last_Name__c}, 

The Guardant360 test you ordered to guide treatment selection for your patient {!Match_Record__c.Patient_Last__Name__c} reported {!Match_Record__c.Qualifying_Target_Genes__c} on {!Match_Record__c.Final_Report_Date__c}. We found that this alteration could qualify your patient for the {!Match_Record__c.Trial_Name__c} clinical trial at your institution. 

The Principal Investigator for {!Match_Record__c.Trial_Name__c}, [Principal Investigator Name], and their research staff are included on this email. If you would like to learn more about this trial, please reply to [Principal Investigator Name] ([PI email]) and their team.  

To view the patient’s Guardant360 report in our secure online portal, click the following link: 
{!Match_Record__c.Portal_Link_For_MD_text__c}. 

Sincerely, 
GuardantConnect Global Access Program 
Guardant Health, Inc.

Guardant Health Match Key: {!Match_Record__c.Match_Key__c}

This message is intended solely for the designated recipient(s). It may contain confidential or proprietary information and may be subject to attorney-client privilege or other confidentiality protections. If you are not a designated recipient you may not review, copy or distribute this message. If you have received this in error, please notify the sender by replying to this e-mail and delete this message. Thank you.</textOnly>
    <type>custom</type>
    <uiType>Aloha</uiType>
</EmailTemplate>
